Terrance P Coyne Net Worth & Insider Trades
Terrance P Coyne - EVP & CFO, Royalty Pharma Plc
What is Terrance P Coyne's Net Worth?
The current estimated net worth of Royalty Pharma Plc's EVP & CFO, Terrance P Coyne, is estimated to be about $11.42M . Terrance P Coyne owns about 994,170 units of Royalty Pharma Plc common stock. In the last 2 years at Royalty Pharma Plc, Terrance P Coyne has sold an estimated value of $10.47M worth.
What is Terrance P Coyne's Past Insider Trading?
Terrance P Coyne's largest purchase order was 26,220 units , worth over $82.6K on June 23, 2020. Terrance P Coyne's largest sale order was 100,000 units , worth over $4.69M on March 4, 2021. In total, Terrance P Coyne has made about 6 transactions over 2 years of their time at Royalty Pharma Plc. Terrance P Coyne usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 30,000 units , worth over $1.3M on August 3, 2022.
Terrance P Coyne
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Terrance P Coyne's Salary in 2020?
The vast majority of their compensation came in the form of other earnings, plans or compensations of $3,395,000 , and
What is Terrance P Coyne's' Mailing Address?
- Mailing address is C/o Royalty Pharma Plc 110 East 59th Street New York NY 10022 NY
Royalty Pharma Plc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|
| Pablo Legorreta Pablo Legorreta | 2020 | $55,674,558 | $55,674,558 | $55,674,558 | $55,674,558 |
| Pablo Legorreta Pablo Legorreta | 2019 | $28,545,792 | $28,545,792 | $28,545,792 | $28,545,792 |
| Terrance Coyne Terrance Coyne | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| Terrance Coyne Terrance Coyne | 2019 | $1,925,625 | $1,925,625 | - | $1,925,625 |
| Christopher Hite | 2020 | $3,644,711 | $3,644,711 | $367,788 | $3,644,711 |
| Christopher Hite | 2019 | - | - | - | - |
| George Lloyd George Lloyd | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| George Lloyd George Lloyd | 2019 | $2,182,500 | $2,182,500 | - | $2,182,500 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2019 | $2,082,500 | $2,082,500 | - | $2,082,500 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm
What are Royalty Pharma Plc's Past Insider Trades?
Royalty Pharma Plc's most recent insider trade came on August 3, 2022 by Terrance P Coyne who sold 30,000 units worth $1.3M . In the last 6 years, insiders at Royalty Pharma Plc have sold an estimated value of $539.97M and bought an estimated value of $146.38M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are George W Lloyd, EVP, James F Reddoch, EVP & Chief Scientific Officer, and Henry A Fernandez, Director .
Royalty Pharma plc Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||